Toxicology ResearchDear Editor, Thank you for the reviews on our submission. The reviewers make some very good suggestions that we have incorporated into the text and the revised manuscript is now much stronger. I shall address the reviewers' comments on a point by point basis.
Referee 1This is a well written paper and the experiments described, though fairly basic, are well performed and analysed. The work explores the mechanism of toxicity of mitragynine, the active alkaloid constituent of the herb Mitragyna speciosa Korth, and suggests a key molecular initiating event (MIE) that triggers the toxicity cascade.We thank the reviewer for the supportive words.
The dose level at which toxicity was seen is 75µM that is some 75,000 to 750fold higher that that found in fairly high level users of the herb. This needs to be included in the abstract.We do mention this fact in the discussion along with the problems of extrapolating in vitro data to the situation in humans. To put our data in context, we also comment upon the human fatalities associated with Kratom consumption. In line with the comment and taking into consideration the reviewer's point 2, we now include new statements in the abstract and expand on this in the discussion. This is a great point. In fact references 9-11 in our manuscript give details of plasma levels of mitragynine in human fatalities associated with Kratom use. The plasma mitragynine concentrations in these individuals varied between 0.45 -1.5 microM, which is 50 fold less than the concentrations used in our studies. We have therefore included a review of these reports in our revised discussion.
It
Shown in both the cytoxicity assays (fig 2B) and clonogenic assays (Fig 2D) the lower doses show a marked cell proliferation. This is not commented on and some text should be included to deal with this.We have amended the text to comment on this. The reviewer makes an important point and we have reviewed the literature around this. We note that there is clear evidence in the literature of opiate mediated cell toxicity, particularly around morphine. In the revised submission we now reference reports of similar observations to ours, regarding naloxone effects on morphine toxicity and their speculation on the role of the µ receptor. Clearly the role of opioid receptors in opiate cellular toxicity remains controversial.
The authors looked at the mechanism and hypothesised that the key molecular event could be interaction with the opiate receptors. This was tested using antagonists against these receptors. Naloxone that has activity particularly against the µ and ҝ receptors showed activity in reducing the toxicity but naltrindole (active against the δ receptor) did not show activity in
Minor comments a. The resolution of figure 1 needs to be improved. This figure has clearly been cut and pasted from elsewhere.We have redrawn the figure using Chem-Draw.
b. Figures 2A and 2B require error bars.We apologise for this oversight. The error bars have been added.
Referee: 2Comments to the Author
The results f...